JAZZ  valuation analysis

Name: Jazz Pharmaceuticals plc
Description: Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 04, 2022
Market cap: $9.31B (492nd)
Sales(TTM): $3.30B (646th)
Earnings(TTM): -$449.85M (1385th)

FFER: 2.92 (why)
Actual price: $148.01
FFEThis is Jazz Pharmaceuticals plc's the estimated price. FFEs are the denominator of the FFER ratio.: $50.74
Quantile: JAZZ is very expensive given its fundamentals.
Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
  • Jazz Pharmaceuticals plc's earnings decreased from $518.28M to -$449.85M in the last year.
Earnings / MarketCap
Jazz Pharmaceuticals plc
"Biotechnology" industry
Sales / MarketCap
Jazz Pharmaceuticals plc
"Biotechnology" industry
Book / MarketCap
Jazz Pharmaceuticals plc
"Biotechnology" industry
Equity / Assets
Jazz Pharmaceuticals plc
"Biotechnology" industry